PDF herunterladen
Ernährung & Medizin 2004; 19(3): 121-128
DOI: 10.1055/s-2004-833693
Gewichtsreduktion

© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Nährstoffsupplemente und Functional Food zur Gewichtsreduktion - Wunsch und Wirklichkeit

Dietary supplements and functional food for body weight reduction - desire and realityAlexander Ströhle, Maike Wolters, Andreas Hahn
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. Dezember 2006 (online)

    Lizenzen und Reprints

Zusammenfassung

Der Wunsch, ganz nebenbei ohne Änderung des Lebensstils, Gewicht zu verlieren, ist ein zentrales Bedürfnis vieler Menschen. Nur so ist es zu erklären, dass »Schlankheitsprodukte« zu den Rennern am Markt zählen. Bereits die Hoffnung auf eine Gewichtsreduktion reicht für viele Verbraucher offenbar aus, elementare - am eigenen Leib erfahrene - Kenntnisse über die Zusammenhänge von Gewicht, Ernährung und Bewegung über Bord zu werfen und sich oft obskuren Heilversprechen hinzugeben. Bei nüchterner wissenschaftlicher Betrachtung erfüllen viele Produkte a priori den Tatbestand des Betrugs und der Irreführung. Dort, wo eine wissenschaftliche Rationale besteht, sind die gewichtsreduzierenden Effekte durchweg gering ausgeprägt, so dass diesen Substanzen eher ein adjuvanter Charakter im Rahmen evidenzbasierter Konzepte zur Gewichtsreduktion zukommen könnte. Der Traum vom Abnehmen im Schlaf bleibt dagegen genau das - ein Traum!

Summary

Many people are dreaming of a body weight reduction without changing the lifestyle. This is the reason why slimming products are extremely successful on the market. For many consumers even the hope of weight loss is sufficient to forget their own basic knowledge and experience on the strong association of weight, diet, and physical exercise and to believe in questionable promises instead. Examined scientifically, the advertising promises of such products turn out not to be true in almost any case. Even if there are some data on a biochemical or pharmacological rationale for an efficacy of such a supplement, in clinical trials the extent of weight reduction was small at best. Therefore, the dream to loose weight without changing the lifestyle remains what it used to be - a dream!

Schlüsselwörter

Adipositas - Gewichtsreduktion - Nahrungsergänzungsmittel - Functional Food - Schlankheitsmittel

Key words

Obesity - body weight reduction - dietary supplements - functional food

Literatur

  • 1 Amato P, Morales AJ, Yen SS. effects of chromium picolinate supplementation on insulin sensitivity, lipids, and body composition in healthy, nonobese, older men and women.  Gerontol A Biol Sci Med Sci. 2000;  55 260-263
    PubMedGoogle Scholar
  • 2 Anderson RA. Effects of chromium on body composition and weight loss.  Nutr Rev. 1998;  56 266-270
    PubMedGoogle Scholar
  • 3 Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.  Int J Obes Relat Metab Disord. 1992;  16 269-277
    PubMedGoogle Scholar
  • 4 Atkinson RL. Conjugated linoleic acid for altering body composition and treating obesity. In: Yurawecz MP, Mossoba MM, Kramer JKG, et al. (eds.): Advances in Conjugated Linoleic Acid Research, Vol 1. Champaign, Ilinois: AOCS Press 1999: 348-353
    Google Scholar
  • 5 Bach AC, Babayan VK. Medium-chain triglycerides: An update.  Am J Clin Nutr. 1982;  36 950-962
    PubMedGoogle Scholar
  • 6 Bach AC, Frey A, Lutz O. Clinical and experimental effects of medium-chain triglycerides. A review.  Clin Nutr. 1989;  8 223-235
    PubMedGoogle Scholar
  • 7 Bach AC, Ingenbleek Y, Frey A. The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy?.  J Lipid Res. 1996;  37 708-726
    PubMedGoogle Scholar
  • 8 Bahadori B, Wallner S, Schneider H. et al. . Effects of chromium yeast and chromium picolinate on body composition in obese non-diabetic patients during and after a very-low-calorie diet.  Acta Med Austriaca. 1997;  5 185-187
    PubMedGoogle Scholar
  • 9 Basu S, Riserus U, Turpeinen A, Vessby B.. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity.  Clin Sci (Lond). 2000;  99 511-516
    PubMedGoogle Scholar
  • 10 BgVV (Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin) .Toxikologische und ernährungsphysiologische Aspekte der Verwendung von Mineralstoffen und Vitaminen in Lebensmitteln. Teil I: Mineralstoffe (einschließlich Spurenelemente).  www.lebensmittelmeister.de/Informatives/BgVV/mineralstoffe.pdf
    Google Scholar
  • 11 Biaggioni I, Davis SN. Caffeine: a cause of insulin resistance?.  Diabetes Care. 2002;  25 399-400
    PubMedGoogle Scholar
  • 12 Blankson H, Stakkested JA, Fagertun H. et al. . Conjugated linoleic acid reduces body fat mass in overweight and obese humans.  J Nutr. 2000;  130 2843-2948
    PubMedGoogle Scholar
  • 13 BMVEL (Bundesministerium für Verbraucherschutz, Ernährung und Landwirtschaft) . Bekanntmachung des Widerrufs von Allgemeinverfügungen nach § 47a LMBG;.  Bundesanzeiger 53. 2001;  90
    PubMedGoogle Scholar
  • 14 Boozer CN, Daly PA, Homel P. et al. . Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.  Int J Obes Relat Metab Disord. 2002;  26 593-604
    CrossrefPubMedGoogle Scholar
  • 15 Boozer CN, Nasser JA, Heymsfield SB. et al. . An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.  Int J Obes Relat Metab Disord. 2001;  25 316-324
    CrossrefPubMedGoogle Scholar
  • 16 Borum P, Bennett SG. Carnitine as an essential nutrient.  J Am Coll Nutr. 1986;  5 177-182
    PubMedGoogle Scholar
  • 17 Bracco D, Ferrarra JM, Arnaud MJ. et al. . Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women.  Am J Physiol. 1995;  269 671-678
    PubMedGoogle Scholar
  • 18 Breum L, Pedersen JK, Ahlstrom F, Frimodt-Moller J. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.  Int J Obes Relat Metab Disord. 1994;  18 99-103
    PubMedGoogle Scholar
  • 19 Bulbulian R, Pringle DD, Liddy MS. Chromium picolinate supplementation in male and female swimmers.  Med Sci Sports Exerc. 1996;  28 S111
    PubMedGoogle Scholar
  • 20 Campbell WW, Joseph LJ, Davey SL. et al. . Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men.  J Appl Physiol. 1999;  86 29-39
    PubMedGoogle Scholar
  • 21 Chan S, McCowen KC, Bistrian B. Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition.  Curr Opin Clin Nutr Metab Care. 1998;  1 163-169
    CrossrefPubMedGoogle Scholar
  • 22 Chin SF, Liu W, Storksen JM, Ha YL, Pariza MW. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens.  J Food Compos Anal. 1992;  5 185-197
    CrossrefPubMedGoogle Scholar
  • 23 Clancy SP, Clarkson PM, DeCheke ME. et al. . Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players.  Int J Sport Nutr. 1994;  4 142-153
    PubMedGoogle Scholar
  • 24 Conte A. A non-prescription alternative on weight reduction therapy. Am J Bariatr Med 1993: 17-19
    Google Scholar
  • 25 Cummings SR, Nevitt MC, Browner WS. et al. . Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.  N Engl J Med. 1995;  332 767-773
    CrossrefPubMedGoogle Scholar
  • 26 Daly PA, Krieger DR, Dulloo AG. et al. . Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.  Int J Obes Relat Metab Disord. 1993;  17 73-78
    PubMedGoogle Scholar
  • 27 Deutsche Gesellschaft für Ernährung (DGE) .Referenzwerte für die Nährstoffzufuhr. Frankfurt am Main: Umschau/ Braus 2000: 201-208
    Google Scholar
  • 28 Di Lorenzo C, Williams CM, Hajnal F, Valenzuela JE. Pectin delays gastric emptying and increases satiety in obese subjects.  Gastroenterology. 1988;  95 1211-1215
    PubMedGoogle Scholar
  • 29 Dulloo AG, Fathi M, Mensi N, Girardier L. Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides: a dose-response study in a human respiratory chamber.  Eur J Clin Nutr. 1996;  50 152-158
    PubMedGoogle Scholar
  • 30 Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers.  Am J Clin Nutr. 1989;  49 44-50
    PubMedGoogle Scholar
  • 31 Egger G, Cameron-Smith D, Stanton R. The effectiveness of popular, non-prescription weight loss supplements.  Med J Aust. 1999;  171 604-608
    PubMedGoogle Scholar
  • 32 Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans.  Int J Biosoc Med Res. 1989;  11 163-180
    PubMedGoogle Scholar
  • 33 Gades MD, Stern JS. Chitosan supplementation and fecal fat excretion in men.  Obes Res. 2003;  11 683-688
    PubMedGoogle Scholar
  • 34 Gades MD, Stern JS. Chitosan supplementation does not affect fat absorption in healthy males fed a high-fat diet, a pilot study.  Int J Obes Relat Metab Disord. 2002;  26 119-122
    CrossrefPubMedGoogle Scholar
  • 35 Gaullier JM, Berven G, Blankson H, Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies.  Lipids. 2002;  37 1019-1025
    PubMedGoogle Scholar
  • 36 Girola M, De Bernardi M, Contos S. et al. . Dose effect in lipid-lowerimg activity of a new dietary intetrator (chitosan, garcinia cambogia extract, and chrome).  Acta Toxicol Ther. 1996;  17 25-40
    PubMedGoogle Scholar
  • 37 Graham TE, Rush JW, van Soeren MH. Caffeine and exercise: metabolism and performance.  Can J Appl Physiol. 1994;  19 111-138
    PubMedGoogle Scholar
  • 38 Greenway FL. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.  Obes Rev. 2001;  2 199-211
    CrossrefPubMedGoogle Scholar
  • 39 Greer F, Friars D, Graham TE. Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance.  J Appl Physiol. 2000;  89 1837-1844
    PubMedGoogle Scholar
  • 40 Hahn A, Wolters M, Hanke G. Nahrungsergänzungsmittel. Möglichkeiten und Grenzen.  Dtsch Apoth Ztg. 1999;  139 2470-2482
    PubMedGoogle Scholar
  • 41 Hahn A. Nahrungsergänzungsmittel. Stuttgart: Wissenschaftliche Verlagsgesellschaft 2001
    Google Scholar
  • 42 Hasten DL, Rome EP, Franks BD, Hegsted M. Effects of chromium picolinate on beginning weight training students.  Int J Sport Nutr. 1992;  2 343-50
    PubMedGoogle Scholar
  • 43 Heaney RP. Effects of caffeine on bone and the calcium economy.  Food Chem Toxicol. 2002;  40 1263-1270
    PubMedGoogle Scholar
  • 44 Heymsfield SB, Alison DB, Vasselli JR. et al. . Garcinia cambogia (hydroxycitrit acid) as a potential antiobesity agent. A randomized controlled trial.  JAMA. 1998;  280 1596-1600
    CrossrefPubMedGoogle Scholar
  • 45 Hill JO, Peters JC, Yang D. et al. . Thermogenesis in humans during overfeeding with medium-chain triglycerides.  Metabolism. 1989;  38 641-648
    CrossrefPubMedGoogle Scholar
  • 46 Horton TJ, Geissler CA. Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.  Int J Obes Relat Metab Disord. 1996;  20 91-97
    PubMedGoogle Scholar
  • 47 Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation.  Nutr Rev. 2001;  59 129-139
    PubMedGoogle Scholar
  • 48 Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia.  J Agric Food Chem. 2002;  50 10-22
    CrossrefPubMedGoogle Scholar
  • 49 Joseph LJ, Farrell PA, Davey SL. et al. . Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women.  Metabolism. 1999;  48 546-553
    CrossrefPubMedGoogle Scholar
  • 50 Kaats GR, Blum K, Fisher JA. et al. . Effects of chromium picolinate on body composition: a randomized double-masked placebo-controlled study.  Curr Ther Res. 1996;  57 747-756
    CrossrefPubMedGoogle Scholar
  • 51 Kaats GR, Wiswe JA, Blum K. et al. . The short-term therapeutic efficacy of treating obesity with a plan of improved nutrition and moderate caloric restriction.  Curr Ther Res. 1992;  51 261-274
    PubMedGoogle Scholar
  • 52 Keijzers GB, De BE Galan, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans.  Diabetes Care. 2002;  25 364-369
    CrossrefPubMedGoogle Scholar
  • 53 Kovacs EM, Westerterp-Plantenga MS, Saris WH. et al. . The effect of addition of modified guar gum to a low-energy semisolid meal on appetite and body weight loss.  Int J Obes Relat Metab Disord. 2001;  25 307-315
    CrossrefPubMedGoogle Scholar
  • 54 Kraft J, Jahreis G. Konjugierte Linolsäuren: Genese und metabolische Wirkungen.  Ernährungs-Umschau. 2001;  48 348-355
    PubMedGoogle Scholar
  • 55 Livolsi JM, Adams GM, Laguna PL. The effect of chromium picolinate on muscular strength and body composition in women athletes.  J Strength Cond Res. 2001;  15 161-166
    CrossrefPubMedGoogle Scholar
  • 56 Löffler G, Petrides PE. Koordinierung des Stoffwechsels. In: Löffler G, Petrides P (Hrsg.): Biochemie und Pathobiochemie, 7. Aufl., Berlin, Heidelberg, New York: Springer 2003: 557-578
    Google Scholar
  • 57 Lukaski HC. Chromium as a supplement.  Annu Rev Nutr. 1999;  19 279-302
    CrossrefPubMedGoogle Scholar
  • 58 Lurz R, Fischer R. Carnitin zur Unterstützung der Gewichtsabnahme bei Adipositas.  Ärztezeitschrift für Naturheilverfahren. 1998;  39 12-15
    PubMedGoogle Scholar
  • 59 MacDonald HB. Conjugated linoleic acid and disease prevention: a review of current knowledge.  J Am Coll Nutr. 2000;  19 111S-118S
    PubMedGoogle Scholar
  • 60 Müller SD, Bäumker C. MCT - das Fett, das nicht dick macht. München: Midena 2001
    Google Scholar
  • 61 Mutschler E, Geisslinger G, Kroemer HK, Schäfer-Korting M. Arzneimittelwirkungen. Stuttgart: Wissenschaftliche Verlagsgesellschaft 2001
    Google Scholar
  • 62 Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review.  Eur J Clin Nutr. 1999;  53 831-839
    CrossrefPubMedGoogle Scholar
  • 63 Papamandjaris AA, White MD, Jones PJ. Components of total energy expenditure in healthy young women are not affected after 14 days of feeding with medium- versus long-chain triglycerides.  Obes Res. 1999;  7 273-280
    PubMedGoogle Scholar
  • 64 Pariza MW, Park Y, Cook ME. Conjugated linoleic acid and the control of cancer and obesity.  Toxicol Sci. 1999;  52 107-110
    PubMedGoogle Scholar
  • 65 Pasman WJ, Westerterp-Plantenga MS, Saris WH. The effectiveness of long-term supplementation of carbohydrate, chromium, fibre and caffeine on weight maintenance.  Int J Obes Relat Metab Disord. 1997;  21 1143-1151
    CrossrefPubMedGoogle Scholar
  • 66 Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double-blind trial of chitosan for body weight reduction.  Eur J Clin Nutr. 1999;  53 379-381
    CrossrefPubMedGoogle Scholar
  • 67 Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials.  Am J Med. 2001;  110 724-730
    CrossrefPubMedGoogle Scholar
  • 68 Pittler MH, Stevinson C, Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials.  Int J Obes Relat Metab Disord. 2003;  27 522-529
    CrossrefPubMedGoogle Scholar
  • 69 Popkin BM, Doak CM. The obesity epidemic is a worldwide phenomen.  Nutr Rev. 1998;  56 106-114
    PubMedGoogle Scholar
  • 70 Rath R, Skala I, Rathova E. Metabolic aspects of the use of medium chain triglycerides in the treatment of obesity.  Z Ernährungswissenschaft. 1972;  13 116-124
    PubMedGoogle Scholar
  • 71 Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals.  Annu Rev Nutr. 1998;  18 39-61
    CrossrefPubMedGoogle Scholar
  • 72 Riserus U, Basu S, Jovinge S. et al. . Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance.  Circulation. 2002;  106 1925-1929
    CrossrefPubMedGoogle Scholar
  • 73 Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome.  Diabetes Care. 2002;  25 1516-1521
    PubMedGoogle Scholar
  • 74 Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial.  Int J Obes Relat Metab Disord. 2001;  25 1129-1135
    CrossrefPubMedGoogle Scholar
  • 75 Rothacker DQ, Waitman BE. Effectiveness of a Garcinia cambogia and natural caffeine combination in weight loss: double-blind placebo-controlled pilot study.  Int J Obes. 1997;  21 53
    PubMedGoogle Scholar
  • 76 Scalfi L, Coltorti A, Contaldo F. Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides.  Am J Clin Nutr. 1991;  53 1130-1133
    PubMedGoogle Scholar
  • 77 SCF (Scientific Committee on Food) .Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Trivalent Chromium (expressed in 4 April 2003). SCF/CS/NUT/UPPLEV/67 Final 23 April 2003. europa.eu.int/comm/food/fs/sc/scf/out197_en.pdf
    Google Scholar
  • 78 Scheck A. L-Carnitin - ein Schlankheitsmittel?.  Ernährungs-Umschau. 1998;  45 131-132
    PubMedGoogle Scholar
  • 79 Scheck A. L-Carnitin: Sinn und Unsinn der Substitution einer körpereigenen Substanz. Teil 1: Zur Physiologie und sinnvollen Substitution.  Ernährungs-Umschau. 1994;  41 9-15
    PubMedGoogle Scholar
  • 80 Scheck A. L-Carnitin: Sinn und Unsinn der Substitution einer körpereigenen Substanz. Teil 2: Zur fragwürdigen und unsinnigen Substitution.  Ernährungs-Umschau. 1994;  41 60-67
    PubMedGoogle Scholar
  • 81 Seaton TB, Welle SL, Warenko MK, Campbell RG. Thermic effect of medium-chain and long-chain triglycerides in man.  Am J Clin Nutr. 1986;  44 630-634
    PubMedGoogle Scholar
  • 82 Siani V. Alim Nutr Metabl.  1984;  5 89-92
    PubMedGoogle Scholar
  • 83 Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects - an update.  J Pharm Pharmacol. 2001;  53 1047-1067
    CrossrefPubMedGoogle Scholar
  • 84 Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans - metabolic effects.  Lipids. 2001;  36 773-781
    PubMedGoogle Scholar
  • 85 St-Onge MP, Bourque C, Jones PJ. et al. . Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women.  Int J Obes Relat Metab Disord. 2003;  27 95-102
    CrossrefPubMedGoogle Scholar
  • 86 St-Onge MP, Jones PJ. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity.  J Nutr. 2002;  132 329-332
    PubMedGoogle Scholar
  • 87 St-Onge MP, Ross R, Parsons WD, Jones PJ. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men.  Obes Res. 2003;  11 395-402
    PubMedGoogle Scholar
  • 88 Stubbs RJ, Harbron CG. Covert manipulation of the ration medium- to long-chain triglycerides in isoenergetically dense diets: effect on food intake in ad libitum feeding men.  Int J Obes. 1996;  20 435-444
    PubMedGoogle Scholar
  • 89 Thakur BR, Singh RK, Handa AK. Chemistry and uses of pectin - a review.  Crit Rev Food Sci Nutr. 1997;  37 47-73
    PubMedGoogle Scholar
  • 90 Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat in healthy exercising humans.  J Int Med Res. 2001;  29 392-396
    PubMedGoogle Scholar
  • 91 Thom E. Hydroxycitrate (HCA) in the treatment of obesity.  Int J Obes. 1996;  20 48
    PubMedGoogle Scholar
  • 92 Tiwary CM, Ward JA, Jackson BA. Effect of pectin on satiety in healthy US Army adults.  J Am Coll Nutr. 1997;  16 423-438
    PubMedGoogle Scholar
  • 93 Toubro S, Astrup AV, Breum L, Quaade F. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/ caffeine mixture.  Int J Obes Relat Metab Disord. 1993;  17 69-72
    PubMedGoogle Scholar
  • 94 Traul KA, Driedger A, Ingle DL, Nakhasi D. Review of the toxicologic properties of medium-chain triglycerides.  Food Chem Toxicol. 2000;  38 79-98
    PubMedGoogle Scholar
  • 95 Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition.  J Sports Med Phys Fitness. 1995;  35 273-280
    PubMedGoogle Scholar
  • 96 Tsuji H, Kasai M, Takeuchi H. et al. . Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women.  J Nutr. 2001;  131 2853-2859
    PubMedGoogle Scholar
  • 97 Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal.  Nutrition. 1996;  12 231-238
    CrossrefPubMedGoogle Scholar
  • 98 Van Wymelbeke V, Himaya A, Louis-Sylvestre J, Fantino M. Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men.  Am J Clin Nutr. 1998;  68 226-234
    PubMedGoogle Scholar
  • 99 Van Wymelbeke V, Louis-Sylvestre J, Fantino M. Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglycerols, or medium-chain triacylglycerols.  Am J Clin Nutr. 2001;  74 620-630
    PubMedGoogle Scholar
  • 100 Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals.  Biochem J. 2002;  361 417-429
    CrossrefPubMedGoogle Scholar
  • 101 Vessby B, Smedman A. Conjugated linoleic acid (CLA) reduces the body fat content in humans.  Chem Phys Lipids. 1999;  101
    PubMedGoogle Scholar
  • 102 Villani RG, Gannon J, Self M, Rich PA. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women.  Int J Sport Nutr Exerc Metab. 2000;  10 199-207
    PubMedGoogle Scholar
  • 103 Vincent JB. The biochemistry of chromium.  J Nutr. 2000;  130 715-718
    PubMedGoogle Scholar
  • 104 Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program.  J Am Coll Nutr. 2001;  20 293-306
    PubMedGoogle Scholar
  • 105 Vukovich MD, Costill DL, Fink WJ. Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise.  Med Sci Sports Exerc. 1994;  26 1122-1129
    PubMedGoogle Scholar
  • 106 Walker LS, Bemben MG, Bemben DA, Knehans AW. Chromium picolinate effects on body composition and muscular performance in wrestlers.  Med Sci Sports Exerc. 1998;  30 1730-1737
    PubMedGoogle Scholar
  • 107 Watson JA, Fang M, Löwenstein JM. Tricarbalyate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxalacetate lyase.  Arch Biochem Biophys. 1969;  35 209-217
    PubMedGoogle Scholar
  • 108 Wirth A. Adipositas. 2. Aufl., Berlin: Springer 2000
    Google Scholar
  • 109 White MD, Papamandjaris AA, Jones PJ. Enhanced postprandial energy expenditure with medium-chain fatty acid feeding is attenuated after 14 d in premenopausal women.  Am J Clin Nutr. 1999;  69 883-889
    PubMedGoogle Scholar
  • 110 WHO .Obesity: Preventing and managing the global epidemic. Genf: WHO Technical Report Series 894: 2000
    Google Scholar
  • 111 Wolfram G. Aktuelles Interview: Sind MCT-Fette die »Fettsensation«?.  Ernährungs-Umschau. 2001;  48 B45-B46
    PubMedGoogle Scholar
  • 112 Wolters M, Siekmann D, Hahn A. Functional Foods - Aktuelle Situation und Perspektiven.  ERNO. 2001;  2 36-46
    PubMedGoogle Scholar
  • 113 Wu G, Morris Jr. SM. Arginine metabolism: nitric oxide and beyond.  Biochem J. 1998;  336 1-17
    CrossrefPubMedGoogle Scholar
  • 114 Yost TJ, Eckel RH. Hypocaloric feeding in obese women: metabolic effects of medium-chain triglyceride substitution.  Am J Clin Nutr. 1989;  49 326-330
    PubMedGoogle Scholar
  • 115 Yurawecz MP, Mossoba MM, Kramer JKG. et al. .In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ (eds.): Advances in Conjugated Linoleic Acid Research, Vol 1. Champaign, Illinois: AOCS Press 1999
  • 116 Zambel KL, Horn WF, Keim NL. Conjugated linoleic acid supplementation in humans: effects on fatty acid and glycerol kinetics.  Lipids. 2001;  36 767-772
    PubMedGoogle Scholar
  • 117 Zambel KL, Keim NL, Van Loan MD. et al. . Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure.  Lipids. 2000;  35 777-782
    PubMedGoogle Scholar

Prof. Dr. Andreas Hahn

Universität Hannover

Zentrum Angewandte Chemie

Institut für Lebensmittelwissenschaft

Wunstorfer Str. 14

30453 Hannover

eMail: andreas.hahn@lw.uni-hannover.de

      >